2023. STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES. International Journal of Pharmaceutical Sciences and Drug Research. 15, 6 (Nov. 2023), 764–769. DOI:https://doi.org/10.25004/IJPSDR.2023.150610.